Select Medical (NYSE:SEM) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday.
According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “
Several other research analysts also recently weighed in on SEM. ValuEngine raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Bank of America upgraded shares of Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price target for the company in a report on Thursday, January 4th. Wells Fargo & Co initiated coverage on shares of Select Medical in a report on Tuesday, January 30th. They set an “outperform” rating and a $26.00 price target for the company. TheStreet cut shares of Select Medical from a “b-” rating to a “c+” rating in a report on Friday, February 2nd. Finally, Robert W. Baird restated a “buy” rating and set a $26.00 price target on shares of Select Medical in a report on Friday, February 23rd. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Select Medical currently has a consensus rating of “Buy” and an average target price of $20.63.
Select Medical (NYSE:SEM) last released its earnings results on Wednesday, February 21st. The health services provider reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.12. The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.10 billion. Select Medical had a net margin of 3.99% and a return on equity of 14.27%. The firm’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same period last year, the firm posted $0.12 earnings per share. research analysts predict that Select Medical will post 1.07 earnings per share for the current fiscal year.
In other Select Medical news, insider Scott A. Romberger sold 5,000 shares of Select Medical stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $18.46, for a total value of $92,300.00. Following the completion of the sale, the insider now directly owns 167,811 shares in the company, valued at $3,097,791.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Martin F. Jackson sold 134,029 shares of Select Medical stock in a transaction that occurred on Friday, December 22nd. The shares were sold at an average price of $17.05, for a total transaction of $2,285,194.45. Following the completion of the sale, the insider now owns 1,717,944 shares of the company’s stock, valued at $29,290,945.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 139,352 shares of company stock valued at $2,383,002. 19.86% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Elkfork Partners LLC acquired a new stake in Select Medical in the fourth quarter valued at approximately $181,000. Xact Kapitalforvaltning AB acquired a new stake in Select Medical in the fourth quarter valued at approximately $223,000. Macquarie Group Ltd. acquired a new stake in Select Medical in the third quarter valued at approximately $265,000. Sawgrass Asset Management LLC acquired a new stake in Select Medical in the fourth quarter valued at approximately $338,000. Finally, Invictus RG lifted its stake in Select Medical by 433.9% in the third quarter. Invictus RG now owns 18,301 shares of the health services provider’s stock valued at $351,000 after acquiring an additional 14,873 shares during the last quarter. Hedge funds and other institutional investors own 79.80% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/03/14/select-medical-sem-downgraded-by-zacks-investment-research.html.
About Select Medical
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.